放下警:cAMP激活剂可以改善GBM中的免疫疗法
Juyeun Lee1, Kristen E Kay1,2, Michael A Vogelbaum3
1Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.
Cancer immunology research
|September 13, 2023
概括
在由癌症干细胞驱动的质母细胞瘤 (GBM) 瘤中抑制血管形成可能会提高免疫治疗的有效性. 这一策略增强了T细胞的透,为治疗这种侵袭性脑癌提供了一种新方法.
科学领域:
- 神经瘤学神经瘤学
- 癌症免疫疗法癌症免疫疗法
- 瘤微环境是一个微环境.
背景情况:
- 质母细胞瘤 (GBM) 是一种具有不良预后的侵袭性脑癌.
- 针对GBM的有效免疫疗法受到T细胞透到瘤中的差异性限制.
- 癌症干细胞 (CSCs) 在GBM进展和治疗耐药性方面发挥着关键作用.
研究的目的:
- 调查CSC驱动的血管系统在阻碍T细胞透的作用.
- 评估抑制CSC驱动血管生成的潜力,作为增强GBM免疫疗法的策略.
主要方法:
- 利用临床前的GBM模型来研究CSC介导的血管生成.
- 评估了针对CSC的抗血管性策略对T细胞透的影响.
- 评估了联合免疫疗法和抗血管原治疗的疗效.
主要成果:
- 发现CSCs在GBM瘤中驱动异常血管形成.
- 抑制CSC驱动的血管生成导致T细胞透的增加.
- 与单一治疗相比,联合治疗显示出增强的抗瘤活性.
结论:
- 准CSC驱动的血管系统是一个可行的策略,以克服T细胞排除在GBM.
- 这种方法有望提高质母细胞瘤患者免疫治疗的疗效.
相关概念视频
Tumor Immunotherapy
554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
Cancer Vaccines
399
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
399
B Cell Activation and Differentiation
1.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.8K


